NDC 52731-7047 Vision Complex

Product Information

What is NDC 52731-7047?

The NDC code 52731-7047 is assigned by the FDA to the product Vision Complex which is product labeled by Nova Homeopathic Therapeutics, Inc.. The product's dosage form is and is administered via form. The product is distributed in a single package with assigned NDC code 52731-7047-2 1 bottle in 1 box / 50 ml in 1 bottle (52731-7047-1). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.

NDC Product Code52731-7047
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		Vision Complex
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		Nova Homeopathic Therapeutics, Inc.
Labeler Code52731
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.		06-01-2011
Listing Expiration Date What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.		12-31-2017
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I". 		I
NDC Code Structure

What are the uses for Vision Complex?


Product Packages

NDC Code 52731-7047-2

Package Description: 1 BOTTLE in 1 BOX / 50 mL in 1 BOTTLE (52731-7047-1)

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Product Details

Vision Complex Active Ingredients UNII Codes

Vision Complex Inactive Ingredients UNII Codes

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

* Please review the disclaimer below.

Vision Complex Product Label

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Label Table of Contents



Purpose:



Suggested use for one or more of the following symptoms:

Strained or tired eyes from extensive driving, computer use, reading or television.


Usage And Dosage:



For oral use only.


Dosage & Administration



Adults:

    In Acute Phase:
            12-15 drops, every half hour until relief occurs
    When Relief Occurs:
            12-15 drops, 4-6 times per day

Children 2-12 years:

            8-10 drops, 4-6 times per day


Warnings:



Keep out of reach of children.


Warnings



If symptoms persist, consult a physician.

Do not use if ring on bottom of cap is broken or missing.


Active Ingredients:



Aurum metallicum 12X, Belladonna 12X, Cactus grandiflorus 4X, China officinalis 8X, Conium maculatum 8X, Curare 12X, Gelsemium sempervirens 12X, Phosphorus 10X, Ruta graveolens 6X, Veratrum album 6X


Inactive Ingredients:



Alcohol, 20% USP


Otc - Questions



Manufactured by Nova Homeopathic Therapeutics Inc., Albuquerque, New Mexico USA 87109
1-800-225-8094


Package Label.Principal Display Panel



Vision Complex Product


Vision Complex Product - Nova Vision Product

Vision Complex Product - Nova Vision Product

Vision Complex Bottle Label


Vision Complex Box




* Please review the disclaimer below.